Doctor Noreen Butt
Stavanger University Hospital, Stavanger (Norway)
Peri-procedural treatment with high dose Rosuvastatin reduces soluble TNF receptor 1 in patients treated with primary percutaneous coronary intervention for ST elevation myocardial infarction
Event: ESC Congress 2019
Topic: Inflammation
Session: Acute coronary syndromes, coronary artery disease: treatment
Infusion of TRO40303 in patients with ST-elevation myocardial infarction prior to primary percutaneous coronary intervention did not alter levels of inflammatory biomarkers in the MITOCARE study
Event: ESC Congress 2016
Topic: Adjunctive medical therapy
Session: Adjunctive medical therapy in coronary artery disease
ESC 365 is supported by
